.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
McKinsey
UBS
Novartis
Dow
Argus Health
Cantor Fitzgerald
Fuji
Medtronic
Chubb

Generated: January 23, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: dextroamphetamine sulfate

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Impax Labs IncDEXEDRINEdextroamphetamine sulfateCAPSULE, EXTENDED RELEASE;ORAL017078NDA AUTHORIZED GENERICImpax Generics0115-1702-1090 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1702-10)
Impax Labs IncDEXEDRINEdextroamphetamine sulfateCAPSULE, EXTENDED RELEASE;ORAL017078NDA AUTHORIZED GENERICImpax Generics0115-1703-1090 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1703-10)
Impax Labs IncDEXEDRINEdextroamphetamine sulfateCAPSULE, EXTENDED RELEASE;ORAL017078NDA AUTHORIZED GENERICImpax Generics0115-1704-1090 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1704-10)
Impax Labs IncDEXEDRINEdextroamphetamine sulfateCAPSULE, EXTENDED RELEASE;ORAL017078NDAAmedra Pharmaceuticals LLC52054-512-091 BOTTLE in 1 CARTON (52054-512-09) > 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Impax Labs IncDEXEDRINEdextroamphetamine sulfateCAPSULE, EXTENDED RELEASE;ORAL017078NDAAmedra Pharmaceuticals LLC52054-513-091 BOTTLE in 1 CARTON (52054-513-09) > 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Impax Labs IncDEXEDRINEdextroamphetamine sulfateCAPSULE, EXTENDED RELEASE;ORAL017078NDAAmedra Pharmaceuticals LLC52054-514-091 BOTTLE in 1 CARTON (52054-514-09) > 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Impax Labs IncDEXEDRINEdextroamphetamine sulfateCAPSULE, EXTENDED RELEASE;ORAL017078NDA AUTHORIZED GENERICLineage Therapeutics Inc54505-327-0990 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54505-327-09)
Impax Labs IncDEXEDRINEdextroamphetamine sulfateCAPSULE, EXTENDED RELEASE;ORAL017078NDA AUTHORIZED GENERICLineage Therapeutics Inc54505-328-0990 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54505-328-09)
Impax Labs IncDEXEDRINEdextroamphetamine sulfateCAPSULE, EXTENDED RELEASE;ORAL017078NDA AUTHORIZED GENERICLineage Therapeutics Inc54505-329-0990 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54505-329-09)
Actavis ElizabethDEXTROAMPHETAMINE SULFATEdextroamphetamine sulfateCAPSULE, EXTENDED RELEASE;ORAL203901ANDAActavis Pharma, Inc.45963-303-0990 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (45963-303-09)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
US Department of Justice
Johnson and Johnson
Daiichi Sankyo
Deloitte
Boehringer Ingelheim
McKesson
Accenture
US Army
Citi

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot